Latest filing published 20 Sept 2022 for Lucira Health, Inc., €472.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Dan George: trading record in brief
Dan George is a declared insider of Lucira Health, Inc. (finance chief), with filings sourced from SEC (Form 4). Between 9 February 2021 and 18 September 2022, the trades on record add up to 5 filings.
On the market, this insider has only sold: 2 sales, €2,288 in total. Other entries cover 1 share grant. 2022 to date brings no purchases and 2 sales.
Most recently, on 20 September 2022, the filings show an open-market sale worth €472 in Lucira Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Dan George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 343 shares@ US$1.3820.6% of flowCommon StockSEC:0001209191-22-050767:0
- 1,321 shares@ US$1.4579.4% of flowCommon StockSEC:0001209191-22-041961:0
- 15,000 shares0Common StockSEC:0001209191-21-042418:0
3 of 3 declarations
